Publications by authors named "A A Cagatay"
Article Synopsis
- The study aimed to address the lack of research on pneumonia management in immunocompromised patients, focusing on their specific unmet needs.
- An observational study of 140 CAP patients indicated a 30-day mortality rate of 17.8%, with higher fatalities noted in patients with Pseudomonas aeruginosa and in those who did not respond to treatment within three days.
- The findings suggest that early treatment response is crucial for improving outcomes in immunocompromised patients, highlighting a significant area that needs more attention in clinical care.
Candida species are the primary cause of fungal infections in intensive care units (ICUs). Despite the increasing prevalence of Candida-related infections, monitoring the progression of these infections from colonization in COVID-19 ICU patients lacks sufficient information. This study aims prospectively to compare 62 COVID-19 and 60 non-COVID-19 ICU patients from admission to discharge in terms of colonization development, rates, isolated Candida species, risk factors, and Candida infections during hospitalization.
View Article and Find Full Text PDFBackground: To the best of our knowledge, this is the first study to evaluate the effectiveness of specific concentrations of antibiofilm agents, such as N-acetyl cysteine (NAC), rifampicin, and ozone, for the treatment of pan-resistant Klebsiella pneumoniae (PRKp).
Objectives: We evaluated the effectiveness of antibiofilm agents, such as NAC, rifampicin, and ozone, on biofilm formation in PRKp at 2, 6, 24, and 72 h.
Design And Setting: This single-center experimental study was conducted on June 15, 2017, and July 15, 2018, at Istanbul Faculty of Medicine, Istanbul University, Turkey.
Background And Aim: Genes related to the circadian rhythm control various biological processes. The aim of this study was to comprehensively investigate the mutational and mRNA profile of core circadian rhythm genes in hepatocellular cancer (HCC) samples.
Materials And Methods: In this study, the gene profile of a total of 369 patients with HCC was examined over the data obtained from the cancer genome atlas database through-cBioPortal.
Independent risk factors for COVID-19-associated coagulopathy.
Eur Rev Med Pharmacol Sci
August 2023
Objective: Past three years since the beginning of the outbreak, we have obtained satisfactory data on COVID-19. However, data on risk factors of COVID-19-associated coagulopathy (CAC) are extremely limited. Prediction of CAC might be a game changer since it is related to poor prognosis.
View Article and Find Full Text PDF